🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Turkey / NCT07568431
Starting soon Observational

Correlation of Cardiac Index Measured by the PRAM Method With NIRS and Lactate Levels in Pediatric Aortic Coarctation Surgery

NCT07568431 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-05
Last updated
2026-05-05

Condition(s) studied

Aortic CoarctationCardiac Output, Low

Investigational drug(s) / intervention(s)

MostCare (PRAM)Near-Infrared Spectroscopy (NIRS)Arterial Blood Gas with Lactate

MostCare (PRAM): Real-time, calibration-free cardiac index monitoring via arterial pressure waveform analysis using the MostCare™ system. Used as part of routine intraoperative hemodynamic monitoring.

Near-Infrared Spectroscopy (NIRS): Non-invasive monitoring of regional cerebral and renal oxygen saturation (rSO2) using the INVOS™ oximeter as part of standard intraoperative care.

Arterial Blood Gas with Lactate: Arterial blood gas sampling for lactate measurement at four intraoperative time points as part of routine clinical monitoring.

Study summary

This prospective observational study aims to evaluate the correlation between cardiac index measured by the MostCare™ system (Pressure Recording Analytical Method, PRAM) and cerebral/renal regional oxygen saturation measured by near-infrared spectroscopy (NIRS) and arterial lactate levels in neonates and infants (body weight 2.5-3.5 kg, age 0-3 months) undergoing surgical repair of aortic coarctation. Measurements will be recorded at four intraoperative time points: after anesthesia induction, before aortic cross-clamp, 3 minutes after cross-clamp release, and at end of surgery. No additional intervention beyond standard anesthesia and surgical care will be applied.

Eligibility

Sex
ALL
Min age
—
Max age
3 Months
Healthy volunteers
No
Inclusion Criteria: * Neonates and infants planned for surgical repair of aortic coarctation * Body weight between 2.5 and 3.5 kg * Postnatal age between 0 and 3 months * Considered hemodynamically stable for anesthesia and surgery * Written informed consent obtained from legal guardians Exclusion Criteria: * Severe multiorgan dysfunction * Additional major congenital heart defect (e.g., Tetralogy of Fallot, Transposition of Great Arteries, Hypoplastic Left Heart Syndrome) * Surgery requiring cardiopulmonary bypass * Preoperative metabolic acidosis or sepsis * Inability to obtain informed consent from legal guardians

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
SBÜ Konya Şehir Hastanesi Konya Turkey (Türkiye)

More Konya City Hospital trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07568431 on ClinicalTrials.gov ↗ ← All trials in Turkey